ArticleFrontiers in neurology2026
Association between fatigue and functional status among patients with multiple sclerosis.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fatigue is one of the most common and disabling symptoms experienced by patients with multiple sclerosis (MS). This study aimed to assess the association between fatigue and functional status among patients with multiple sclerosis. Methods: A descriptive correlational cross-sectional study was conducted in September 2025 to January 2026, on 78 patients diagnosed with MS using a purposive sampling method, at Nasser Institute Hospital, Egypt. Data were collected using a structured interview questionnaire, the Fatigue Severity Scale, Lawton and Brody's Instrumental Activities of Daily Living Scale (IADL), the MS Walking Scale, and the Social Functioning Questionnaire. Data were analyzed using SPSS version 25. Statistical significance was considered at Results: After assessment using the Fatigue Severity Scale, 46.1% of participants were classified as having severe fatigue, 52.6% had moderate fatigue, and 1.3% had mild fatigue. Female participants reported higher fatigue scores than males. More than half of the participants demonstrated impaired social functioning, and a considerable proportion exhibited dependence in instrumental activities of daily living and moderate-to-severe walking impairment. Significant positive correlations were observed between fatigue severity and dependence in instrumental activities of daily living, walking impairment, and social dysfunction (all Conclusion: Fatigue is highly prevalent among patients with MS and is significantly associated with poorer functional status, particularly reduced instrumental activities of daily living and greater walking impairment. Routine assessment of fatigue and the development of comprehensive fatigue-management strategies may help identify patients at risk of functional limitations and support the delivery of individualized care aimed at maintaining independence, mobility, and quality of life among individuals with MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.